Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy ... and is in phase 1 for lupus nephritis. According to the American ...

The chronic kidney disease drug development landscape is evolving at an unprecedented pace, driven by breakthrough approvals, billion-dollar mergers and acquisitions, and increasing regulatory support ...

adding a mid-stage drug candidate for kidney disease IgA nephropathy (IgAN). The $65-per-share deal is due to close within the next three months, said Vertex, which plans to fund the acquisition ...

Piper Sandler adjusted its stance on Q32 Bio Inc. (NASDAQ: QTTB), downgrading the biotech firm's stock rating from Overweight to Neutral and significantly reducing the price target to $4.00 from the ...

The addition of obinutuzumab to standard care increased the complete renal response rate by 13.4 percentage points in patients with active proliferative lupus nephritis. Obinutuzumab, an anti-CD20 ...

Q4 2024 Earnings Call Transcript February 12, 2025 Operator: Good morning. My name is Jennifer and I will be your conference ...

Systemic lupus erythematosus (SLE) is an autoimmune disease that sometimes involves the central nervous system in a condition known as neuropsychiatric SLE (NPSLE). Research in mice has shown that ...

Iga Swiatek defeated Maria Sakkari in the Round of 32 at the Qatar Open. / IMAGO / ZUMA Press Wire Iga Swiatek is back in one of her favorite tournaments, and she looked strong in her first match ...

Correspondence to Dr Chi Chiu Mok, Department of Medicine, Tuen Mun Hospital, Hong Kong; ccmok2005{at}yahoo.com Objective To compare the efficacy of tacrolimus (TAC) and mycophenolate mofetil (MMF) ...

Objective Randomised trials of type I anti-CD20 antibodies rituximab and ocrelizumab failed to show benefit in proliferative lupus nephritis (LN). We compared obinutuzumab, a humanised type II ...

1 seed Iga Swiatek captured her 21st career title and fourth of 2024 at the Internazionali BNL d'Italia without dropping a set. Swiatek became the sixth player in the Open Era to win three or more ...